Physician profile
Mandip Joshi
NPI 1891945002
$13,139.76
in general payments reported to CMS, 2019-2025
11 companies · $35.00 in 2025
The $35.00 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2022: $671 · 2023: $11K · 2024: $1,160 · 2025: $35.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,585 · Travel and Lodging: $4,120 · Food and Beverage: $1,489 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,584.90 |
| Travel and Lodging | $4,120.08 |
| Food and Beverage | $1,489.43 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,433.28 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $1,067.48 | 2024 | Apollo Esg Nxt System |
| Novo Nordisk INC | $242.41 | 2022-2024 | Wegovy |
| Ethicon US, LLC | $125.00 | 2019 | |
| W. L. Gore & Associates, INC. | $115.44 | 2019 | |
| Phathom Pharmaceuticals, INC. | $35.00 | 2025 | Voquezna |
| Teleflex LLC | $30.54 | 2023 | Titan Sgs Standard Gastric Stapler |
| Shield Therapeutics INC | $27.79 | 2024 | |
| Lilly USA, LLC | $23.00 | 2024 | Zepbound |
| Medtronic, INC. | $20.85 | 2022 | |
| Daiichi Sankyo INC. | $18.97 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandip Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.